Early Supportive Care Extends Life, Eases Cancer Symptoms
“Anna Bass, 62, of Victoria, Virginia, had been a longtime smoker, so she was not surprised in October 2016 when she was diagnosed with adenocarcinoma in her right lung. Her doctor had noticed a small spot on a CT scan two years earlier after she quit smoking. She had opted to hold off treatment, hoping that the lesion would not grow larger.”

Genomic Profiling for Lung Cancer: Improving Access to this Important Tool
“Lung cancer is the second most commonly diagnosed cancer worldwide, after breast cancer, with over 2.2 million new cases recorded in 2020 by the World Health Organization’s International Agency for Research on Cancer. It also accounted for nearly 1.8 million deaths in that year, making it the leading cause of cancer mortality.”

A lung cancer wake-up call
“City of Hope’s advanced techniques helped detect Devonne Swift’s lung cancer at an early stage, when it was treatable”

Lung Cancer Trial Has Broader Eligibility Criteria, Overcomes Barriers
“The National Cancer Institute (NCI) launched the phase 3 Pragmatica-Lung Study (S2302) clinical trial evaluating Cyramza (ramucirumab) plus Keytruda (pembrolizumab) for patients with stage 3 or recurrent non-small cell lung cancer, according to a press release from the agency.”

Does Smoking Weed Cause Lung Cancer?
“We’ve long known the connection between cigarettes and lung cancer. But does smoking weed lead to the same serious health problems?”

Cedars-Sinai Cancer collaborates on a streamlined clinical trial design in Pragmatica-Lung Study
“Investigators from Cedars-Sinai Cancer are collaborating on a streamlined clinical trial design in a study called Pragmatica-Lung. This randomized Phase III trial funded by the National Cancer Institute (NCI), part of the National Institutes of Health, will test a therapy for advanced non-small cell lung cancer in a real-world patient population, with a focus on just one major question: Does this therapy help patients live longer?”

Durvalumab-based Treatment Before and After Surgery Improved Outcomes for Patients With Resectable Non-small Cell Lung Cancer
“ORLANDO, Fla. – Patients with treatment-naïve resectable non-small cell lung cancer (NSCLC) who received neoadjuvant durvalumab (Imfinzi) plus chemotherapy and adjuvant durvalumab monotherapy had improved event-free survival (EFS) and pathological complete response (pCR) compared with those who received neoadjuvant chemotherapy alone, according to results from the phase III placebo-controlled AEGEAN clinical trial, which were presented at the AACR Annual Meeting 2023, held April 14-19.”

Traces of ancient viruses in DNA of humans could help fight cancer: Study
“A study has found that remnants of million-year-old viruses passed down in humans, could have been hiding inside DNA, and might help the body fight cancers. Scientists believe that the findings could be useful to treat more people to survive lung cancer.”

Immunotherapy-Based Treatment Improves Lung Cancer Outcomes Pre- and Post-Surgery, Says AACR
“ORLANDO, Fla. ― A regimen of pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy significantly improved event-free survival (EFS) and pathologic complete response (pCR) rates compared to chemotherapy alone for patients with operable non-small cell lung cancer (NSCLC), according to Phase III trial results presented today by researchers from The University of Texas MD Anderson Cancer Center at the American Association for Cancer Research (AACR) Annual Meeting 2023.”

Estimated Lung Cancer Screening Rates “Extremely Low” Across Insurance Types
“Rates of lung cancer screening with low-dose CT (LDCT) were extremely low among eligible patients across insurance types in 2017, with rates varying between patient demographics, according to a study published in Journal of the American College of Radiology.1

Taking Cancer Support to a New Level
“When patients are undergoing treatment for lung cancer, the expected focus is on treatment options and details. Patients and their families may be surprised when the topic of supportive or palliative care enters the conversation with their cancer team. Patients may assume that supportive or palliative care means end-of-life care, when in fact it is meant to improve a patient’s quality of life during treatment.”

Does Vaping Cause Lung Cancer?
“E-cigarettes are too new for experts to know much about long-term health consequences, but preliminary research suggests that vaping is likely to lead to serious lung problems.”

AI-Based Denoising Technique Achieves 76 Percent Reduction in Radiation Dosing for CT Lung Cancer Screening
“New prospective research demonstrated that the combination of ultra-low-dose (ULD) computed tomography (CT) and an artificial intelligence (AI)-based denoising method offered a greater than 95 percent sensitivity rate for differentiating negative and actionable Lung-RADS category findings with significantly reduced radiation dosing.”